175 related articles for article (PubMed ID: 22194938)
21. The three Type 2A protein phosphatases, PP2Ac, PP4c and PP6c, are differentially regulated by Alpha4.
LeNoue-Newton ML; Wadzinski BE; Spiller BW
Biochem Biophys Res Commun; 2016 Jun; 475(1):64-9. PubMed ID: 27169767
[TBL] [Abstract][Full Text] [Related]
22. alpha4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein.
McDonald WJ; Sangster SM; Moffat LD; Henderson MJ; Too CK
J Cell Biochem; 2010 Aug; 110(5):1123-9. PubMed ID: 20544796
[TBL] [Abstract][Full Text] [Related]
23. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.
Liu J; Prickett TD; Elliott E; Meroni G; Brautigan DL
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6650-5. PubMed ID: 11371618
[TBL] [Abstract][Full Text] [Related]
25. Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3.
Gordon J; Hwang J; Carrier KJ; Jones CA; Kern QL; Moreno CS; Karas RH; Pallas DC
BMC Biochem; 2011 Oct; 12():54. PubMed ID: 21985334
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of protein phosphatase 2A stable latency.
Jiang L; Stanevich V; Satyshur KA; Kong M; Watkins GR; Wadzinski BE; Sengupta R; Xing Y
Nat Commun; 2013; 4():1699. PubMed ID: 23591866
[TBL] [Abstract][Full Text] [Related]
27. Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A.
Inui S; Sanjo H; Maeda K; Yamamoto H; Miyamoto E; Sakaguchi N
Blood; 1998 Jul; 92(2):539-46. PubMed ID: 9657754
[TBL] [Abstract][Full Text] [Related]
28. TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis.
Collison AM; Li J; de Siqueira AP; Lv X; Toop HD; Morris JC; Starkey MR; Hansbro PM; Zhang J; Mattes J
BMC Pulm Med; 2019 Feb; 19(1):31. PubMed ID: 30732588
[TBL] [Abstract][Full Text] [Related]
29. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the human Tip41 orthologue, TIPRL, reveals a novel fold and a binding site for the PP2Ac C-terminus.
Scorsato V; Lima TB; Righetto GL; Zanchin NI; Brandão-Neto J; Sandy J; Pereira HD; Ferrari ÁJ; Gozzo FC; Smetana JH; Aparicio R
Sci Rep; 2016 Aug; 6():30813. PubMed ID: 27489114
[TBL] [Abstract][Full Text] [Related]
31. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
32. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
[TBL] [Abstract][Full Text] [Related]
33. TRPC1-mediated Ca
Rathor N; Chung HK; Song JL; Wang SR; Wang JY; Rao JN
Physiol Rep; 2021 May; 9(9):e14864. PubMed ID: 33991460
[TBL] [Abstract][Full Text] [Related]
34. The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity.
Sents W; Ivanova E; Lambrecht C; Haesen D; Janssens V
FEBS J; 2013 Jan; 280(2):644-61. PubMed ID: 22443683
[TBL] [Abstract][Full Text] [Related]
35. Conformation of human serum apolipoprotein A-I(166-185) in the presence of sodium dodecyl sulfate or dodecylphosphocholine by 1H-NMR and CD. Evidence for specific peptide-SDS interactions.
Wang G; Treleaven WD; Cushley RJ
Biochim Biophys Acta; 1996 Jun; 1301(3):174-84. PubMed ID: 8664326
[TBL] [Abstract][Full Text] [Related]
36. Structure and dynamics of helix-0 of the N-BAR domain in lipid micelles and bilayers.
Löw C; Weininger U; Lee H; Schweimer K; Neundorf I; Beck-Sickinger AG; Pastor RW; Balbach J
Biophys J; 2008 Nov; 95(9):4315-23. PubMed ID: 18658220
[TBL] [Abstract][Full Text] [Related]
37. I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A.
Chen S; Li B; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2008 Apr; 283(16):10513-21. PubMed ID: 18245083
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological disruption of the MID1/α4 interaction reduces mutant Huntingtin levels in primary neuronal cultures.
Monteiro O; Chen C; Bingham R; Argyrou A; Buxton R; Pancevac Jönsson C; Jones E; Bridges A; Gatfield K; Krauß S; Lambert J; Langston R; Schweiger S; Uings I
Neurosci Lett; 2018 Apr; 673():44-50. PubMed ID: 29499308
[TBL] [Abstract][Full Text] [Related]
39. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
[TBL] [Abstract][Full Text] [Related]
40. NMR conformational studies of micelle-bound orexin-B: a neuropeptide involved in the sleep/awake cycle and feeding regulation.
Miskolzie M; Lucyk S; Kotovych G
J Biomol Struct Dyn; 2003 Dec; 21(3):341-51. PubMed ID: 14616030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
